These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8665481)

  • 1. Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells.
    Miniati DN; Chang Y; Shu WP; Peehl DM; Liu BC
    Cancer Lett; 1996 Jul; 104(2):137-44. PubMed ID: 8665481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
    Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY; Zelner DJ; Lee C
    Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prostatic carcinoma cell proliferation and secretory activity by extracellular matrix and stromal secretions.
    Fong CJ; Sherwood ER; Braun EJ; Berg LA; Lee C; Kozlowski JM
    Prostate; 1992; 21(2):121-31. PubMed ID: 1384014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
    Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
    Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: role of heparin/heparan-degrading enzymes.
    Kassen AE; Sensibar JA; Sintich SM; Pruden SJ; Kozlowski JM; Lee C
    Prostate; 2000 Jul; 44(2):124-32. PubMed ID: 10881022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
    Lee C; Sutkowski DM; Sensibar JA; Zelner D; Kim I; Amsel I; Shaw N; Prins GS; Kozlowski JM
    Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
    Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
    Thelen P; Jarry H; Ringert RH; Wuttke W
    Planta Med; 2004 May; 70(5):397-400. PubMed ID: 15124082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix.
    Guo Y; Pili R; Passaniti A
    Prostate; 1994; 24(1):1-10. PubMed ID: 7507237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone.
    McCulloch DR; Harvey M; Herington AC
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):11-21. PubMed ID: 11000516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
    J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.
    Lin MF; Garcia-Arenas R; Chao YC; Lai MM; Patel PC; Xia XZ
    Arch Biochem Biophys; 1993 Jan; 300(1):384-90. PubMed ID: 8424672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line.
    Kirschenbaum A; Ren M; Levine AC
    Steroids; 1993 Sep; 58(9):439-44. PubMed ID: 8236330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells.
    Bruckheimer EM; Kyprianou N
    Endocrinology; 2001 Jun; 142(6):2419-26. PubMed ID: 11356690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines.
    Blanchère M; Saunier E; Mestayer C; Broshuis M; Mowszowicz I
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):297-304. PubMed ID: 12589936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
    Sherwood ER; Van Dongen JL; Wood CG; Liao S; Kozlowski JM; Lee C
    Br J Cancer; 1998 Mar; 77(6):855-61. PubMed ID: 9528825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
    Dulińska J; Laidler P; Labedź M
    Acta Biochim Pol; 2002; 49(2):357-68. PubMed ID: 12362977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.